Back to Search
SALAH RAFATI, M.D.
M.D.
Diagnostic Radiology Physician
NPI: 1629092267Individual
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
E4146(TX)
Research & Publications (20)
The efficiency of a novel delivery system (PEI600-Tat) in development of potent DNA vaccine using HPV16 E7 as a model antigen.
PMID 19514980·Drug Deliv·2009
7-preclinical
Polytope DNA vaccine development against hepatitis C virus: a streamlined approach from in silico design to in vitro and primary in vivo analyses in BALB/c mice.
PMID 19601916·Protein Pept Lett·2009
7-preclinical
Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient mice.
PMID 19185172·J Thorac Cardiovasc Surg·2009
7-preclinical
Searching for virulence factors in the non-pathogenic parasite to humans Leishmania tarentolae.
PMID 19416551·Parasitology·2009
7-preclinical
Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis.
PMID 18424735·J Immunol·2008
7-preclinical
Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice.
PMID 18093586·Exp Parasitol·2008
7-preclinical
Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies.
PMID 18471945·Vaccine·2008
4-observational
The profile of cytokines and IgG subclasses in BALB/c mice after immunization with Brucella ribosomal gene.
PMID 19205266·Pak J Biol Sci·2008
7-preclinical
Heat-shock proteins as powerful weapons in vaccine development.
PMID 18844593·Expert Rev Vaccines·2008
6-review
Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals.
PMID 18804512·Vaccine·2008
7-preclinical
The dense granule protein GRA2, a new marker for the serodiagnosis of acute Toxoplasma infection: comparison of sera collected in both France and Iran from pregnant women.
PMID 17509806·Diagn Microbiol Infect Dis·2007
4-observational
Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice.
PMID 17418457·Vaccine·2007
7-preclinical
Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients.
PMID 17395340·Vaccine·2007
7-preclinical
Amastin peptide-binding antibodies as biomarkers of active human visceral leishmaniasis.
PMID 17028214·Clin Vaccine Immunol·2006
7-preclinical
Leishmaniasis vaccine candidates for development: a global overview.
PMID 16778321·Indian J Med Res·2006
6-review
Protective efficiency of dendrosomes as novel nano-sized adjuvants for DNA vaccination against birch pollen allergy.
PMID 16515817·J Biotechnol·2006
7-preclinical
Comparison of potential protection induced by three vaccination strategies (DNA/DNA, Protein/Protein and DNA/Protein) against Leishmania major infection using Signal Peptidase type I in BALB/c mice.
PMID 16481076·Vaccine·2006
4-observational
Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis.
PMID 16325969·Vaccine·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5401 SPRINGFIELD AVE
LAREDO, TX 78041 - Phone
- (956) 718-0092
Quick Facts
- NPI
- 1629092267
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile